A study by the Comprehensive Cancer Center Vienna of MedUni Vienna and Vienna General Hospital has taken a closer look at the effectiveness of common examination methods for the early detection of prostate cancer.
Lisata shares pipeline update of anticancer lead candidate drug
Lisata aims to finish enrolment of its Phase II trial in solid tumours by the end of 2024. Image Credit: Shutterstock / Elif Bayraktar. Lisata